Skip to main content

Clinical Trials Using Protective Agent

Review the clinical trials studying protective agent on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-25 of 62

Accelerated or Standard BEP Chemotherapy in Treating Patients with Intermediate or Poor-Risk Metastatic Germ Cell Tumors
Status: Active
Location: 170 locations
A Study of a New Way to Treat Children and Young Adults with a Brain Tumor Called NGGCT
Status: Active
Location: 145 locations
Testing the Use of Steroids and Tyrosine Kinase Inhibitors with Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
Status: Active
Location: 199 locations
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Status: Active
Location: 99 locations
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Status: Active
Location: 28 locations
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
Status: Active
Location: 6 locations
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Status: Active
Location: 6 locations
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Status: Active
Location: 5 locations
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Status: Active
Location: 3 locations
Standard Chemotherapy and Short or Long Course Radiation Therapy with or without BMX-001 for the Treatment of Stage II-III Rectal Cancer
Status: Active
Location: 3 locations
ADI-PEG 20 with Ifosfamide and Mesna in Combination with Radiation Therapy for the Treatment of Soft Tissue Sarcoma Prior to Surgical Resection
Status: Active
Location: 4 locations
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Status: Active
Location: 3 locations
Troriluzole for the Treatment of Recurrent IDH Wild Type Glioblastoma
Status: Active
Location: 3 locations
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Status: Active
Location: 3 locations
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Status: Active
Location: 2 locations
Ascorbic Acid with Gemcitabine and Carboplatin for Treating Patients with Muscle Invasive Bladder Cancer
Status: Active
Location: 2 locations
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Status: Active
Location: 3 locations
Cytokine Induced Memory-Like Natural Killer Cells in Combination with Aldesleukin for the Treatment of Locally Advanced or Metastatic Renal Cell Cancer or Urothelial Cancer
Status: Active
Location: 2 locations
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
Status: Active
Location: Icahn School of Medicine at Mount Sinai, New York, New York
Niacinamide for the Treatment of Patients with Chronic Lymphocytic Leukemia with History of Non-melanoma Skin Cancer
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Iobenguane I-131 in Treating Patients with Recurrent Neuroblastoma, Malignant Pheochromocytoma, or Malignant Paraganglioma
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients with High-Risk Neuroblastoma
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Specialized Stem Cell Transplant Product (Hematopoietic Progenitor Blood Cell Graft Cells) for the Treatment of Children, Adolescent and Young Adult Patients with Hematologic Cancers
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Ruxolitinib and Donor Stem Cell Transplant for the Treatment of Myelofibrosis Patients with Splenomegaly
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas